Aurolife Pharma, LLC recalls Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08
Recalled December 28, 2022 · FDA recall D-0087-2023 · Aurolife Pharma
Hazard
Failed Impurities/Degradation Specifications · FDA Class II
Units
7344 bottles
Sold at
Nationwide in the USA and Puerto Rico.
Description
Failed Impurities/Degradation Specifications
Product
Glycopyrrolate Tablets, USP, 1 mg, 100 tablets, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
Manufacturer(s)
Aurolife Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →